Abstract
Safety and antigenicity of a purified preparation of Salmonella typhosa Vi antigen was evaluated in human volunteers. Dosages of Vi antigen at 25, 50, and 100 μg were less toxic than U.S. standard typhoid vaccine (lot 6A) containing 5 x 108 bacteria oer dosage. Vi antigen in comparison with the standard typhoid vaccine induced higher hemagglutinating antibody but lower bactericidal antibody responses.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1290-1294 |
| Number of pages | 5 |
| Journal | Unknown Journal |
| Volume | 12 |
| Issue number | 6 |
| DOIs | |
| State | Published - 1975 |
All Science Journal Classification (ASJC) codes
- Parasitology
- Microbiology
- Immunology
- Infectious Diseases
Fingerprint Dive into the research topics of 'Vi antigen from Salmonella typhosa and immunity against typhoid fever. II. Safety and antigenicity in humans'. Together they form a unique fingerprint.
Cite this
Levin, D. M., Wong, K. H., Reynolds, H. Y., Sutton, A., & Northrup, R. S. (1975). Vi antigen from Salmonella typhosa and immunity against typhoid fever. II. Safety and antigenicity in humans. Unknown Journal, 12(6), 1290-1294. https://doi.org/10.1128/iai.12.6.1290-1294.1975